DIVIDEND ANNOUNCEMENT: AbbVie Inc (NYSE:ABBV) on 02/15/2024 declared a dividend of $1.5500 per share

AbbVie Inc (NYSE:ABBV) on 02/15/2024 declared a dividend of $ 1.5500 per share payable on May 15, 2024 to shareholders of record as of April 15, 2024.

AbbVie Inc (NYSE:ABBV) has paid dividends since 2013, has a current dividend yield of 3.5546381474% and has increased its dividends for 10 successive years.

AbbVie Inc's market cap is $ 307,944,963,540 and has a PE ratio of 47.66. The stock price closed yesterday at $ 174.42 and has a 52 week low/high of $ 130.96 and $ 175.91.

AbbVie is a research-based biopharmaceutical company. Co. operates as a single business segment dedicated to the research and development, manufacturing, commercialization and sale of medicines and therapies. Co.'s products include: immunology products such as Humira, Skyrizi, and Rinvoq; oncology products such as Imbruvica and Venclexta/Venclyxto; aesthetics products such as Botox Cosmetic and The Juvederm Collection of Fillers; neuroscience products such as Botox Therapeutic, Vraylar, and Ubrelvy; eyecare products such as Lumigan/Ganfort, Alphagan/Combigan, and Restasis; women's health products such as Lo Loestrin and Orilissa/Oriahnn; and other key products such as Creon and Synthroid.

For more information on AbbVie Inc click here.